• Brainstorm Health: Amarin Stock, Drug Pricing Bill, Gaming Disorder Debate

    5 monthes ago - By Fortune

    Good afternoon, readers.
    Shares of Ireland-based biopharma Amarin Corporation spiked more than 20% in Thursday trading-a jump that adds to the “fish oil pill” company's bullish run since the beginning of the JPMorgan Healthcare conference on Monday. Amarin stock is up 45% in the past five days.
    Two separate, and related, factors are likely driving the trend: Impressive presentations by Amarin CEO John Thero during investor presentations at the JPM conference (I interviewed Thero on Monday evening, and he projected the sort of product confidence that often proves catnip to the shareholder...
    Read more ...